Achieving Osmotic Stability in the Context of Critical Illness and Acute Kidney Injury During Continuous Renal Replacement Therapy. Issue 7 (July 2020)

• Record Type: Journal Article
• Authors: Fang, Diana; Chabrier-Rosello, Jorge O.; McMahon, Blaithin A.; Fülöp, Tibor; Achanti, Anand
• Is Part Of: ASAIO journal. Volume 66:Issue 7(2020)
• Publication Date: 2020-07
• Subjects: cardiac arrest -- glucocorticoid therapy -- hypertonic saline solution -- continuous veno-venous hemodiafiltration -- osmolality -- tonicity; Artificial organs -- Periodicals; 617
• DOI: 10.1097/MAT.0000000000001100
• Languages: English
• ISSNs: 1058-2916

Abstract

Abstract : The concept of osmotic stability during renal replacement therapy has received limited attention thus far. We report an illustrative case of a previously healthy 22 year old male presenting after prolonged ventricular fibrillation with 75 minutes of resuscitative efforts before regaining spontaneous perfusing rhythm. Central nervous system protecting hypothermia protocol and veno-arterious (VA) extracorporeal membrane oxygenator (ECMO) therapy were initiated at hospital admission due to refractory hypoxemia. Cardiovascular imaging procedures described global hypokinesis. Due to the combination of anuria, mixed acidosis and hemodynamic instability, we started continuous renal replacement therapy (CRRT) in continuous veno-venous hemodiafiltration functionality with added hypertonic saline solution (HTS) protocol, calculated to stabilize his serum sodium between 148 and 150 mEq/L. Serum osmolality also ranged between 321 and 317 mOsm/kg thereafter. Course was complicated by an acute right leg ischemia distal to VA ECMO cannula placement, requiring salvage therapy with cryoamputation. Vasoactive medication requirement and hemodynamics improved after the addition of intravenous (IV) hydrocortisone. Brain magnetic resonance imaging (MRI) 22 days post-arrest showed signals of limited hypoxic injury. He left the hospital in stable condition with limited neurologic sequelae. Therefore, the use of HTS during CRRT is a viable way to address potential or manifest cerebral edema and reduce the degree of cerebral injury.